IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 90 filers reported holding IGM BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,413,326 | -29.4% | 768,063 | -22.0% | 0.00% | -25.0% |
| Q2 2023 | $9,088,439 | +1150335.3% | 984,663 | +1613.6% | 0.00% | – |
| Q1 2023 | $790 | -86.1% | 57,460 | -82.8% | 0.00% | -100.0% |
| Q4 2022 | $5,684 | -99.9% | 334,185 | +14.8% | 0.00% | -25.0% |
| Q3 2022 | $6,622,000 | -37.7% | 291,215 | -50.6% | 0.00% | -42.9% |
| Q2 2022 | $10,627,000 | +79.6% | 589,401 | +166.3% | 0.01% | +133.3% |
| Q1 2022 | $5,916,000 | +23.2% | 221,312 | +35.1% | 0.00% | +50.0% |
| Q4 2021 | $4,803,000 | +60.5% | 163,754 | +259.8% | 0.00% | 0.0% |
| Q3 2021 | $2,993,000 | +30.1% | 45,514 | +51.7% | 0.00% | 0.0% |
| Q1 2021 | $2,301,000 | +551.8% | 30,000 | +650.0% | 0.00% | – |
| Q4 2020 | $353,000 | -78.5% | 4,000 | -82.0% | 0.00% | -100.0% |
| Q3 2020 | $1,641,000 | -51.6% | 22,231 | -52.1% | 0.00% | -60.0% |
| Q2 2020 | $3,390,000 | +559.5% | 46,445 | +406.9% | 0.01% | +400.0% |
| Q1 2020 | $514,000 | -88.6% | 9,162 | -96.4% | 0.00% | -85.7% |
| Q3 2019 | $4,504,000 | – | 253,790 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |